Efficacy News and Research

RSS
AstraZeneca responds to FDA advisory committees' recommendation on SYMBICORT

AstraZeneca responds to FDA advisory committees' recommendation on SYMBICORT

Vaxfectin-formulated H5N1 pandemic influenza achieves T-cell responses and cross-clade reactivity in humans

Vaxfectin-formulated H5N1 pandemic influenza achieves T-cell responses and cross-clade reactivity in humans

AEterna Zentari completes recruitment for phase 3 trial with Cetrorelix in benign prostatic hyperplasia

AEterna Zentari completes recruitment for phase 3 trial with Cetrorelix in benign prostatic hyperplasia

Studies on imaging and tracking transplanted cells

Studies on imaging and tracking transplanted cells

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

FDA grants compassionate case for use of novel wet age-related macular degeneration treatment

FDA grants compassionate case for use of novel wet age-related macular degeneration treatment

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Experimental drug successfully blocks mutation in bone marrow cancers

Experimental drug successfully blocks mutation in bone marrow cancers

Portola Pharmaceuticals starts phase 2 trial of P2Y12 ADP receptor antagonist in non-urgent percutaneous coronary intervention

Portola Pharmaceuticals starts phase 2 trial of P2Y12 ADP receptor antagonist in non-urgent percutaneous coronary intervention

AcelRx Pharmaceuticals reports positive results in trial of sublingual Sufentanil NanoTabs in treating post-op pain

AcelRx Pharmaceuticals reports positive results in trial of sublingual Sufentanil NanoTabs in treating post-op pain

Researchers discover why Gleevec-type drugs control, but do not eradicate leukemia

Researchers discover why Gleevec-type drugs control, but do not eradicate leukemia

Promising trials of malaria vaccine in East Africa lead to calls for phase 3 development

Promising trials of malaria vaccine in East Africa lead to calls for phase 3 development

Novel approach to disseminate trial results to study volunteers

Novel approach to disseminate trial results to study volunteers

Gene therapy used to fight AIDS

Gene therapy used to fight AIDS

Effects of stem cell source and patient age on stem cell transplantation outcomes

Effects of stem cell source and patient age on stem cell transplantation outcomes

New approaches to prevent blood clots

New approaches to prevent blood clots

Kiadis Pharma announces positive results for ATIR in mismatched bone marrow transplantation

Kiadis Pharma announces positive results for ATIR in mismatched bone marrow transplantation

ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%

ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.